- News in Brief
- Published:
Nature Biotechnology volume 44, page 1594 (2026) Cite this article
Scientists from Ataturk University use gene editing to increase the growth of rainbow trout. Injecting two guide RNAs targeting the first exon of the myostatin gene mstnb1 into fertilized rainbow trout eggs, the team was able to increase the trouts’ body weight by 56%. The results suggest that CRISPR–Cas9 could help shorten production time and improve production efficiency in aquaculture.
Seoul-based pharma DuChemBio will build Korea’s first plant dedicated to radiopharmaceuticals after agreeing to a $25.5 million contract with North Jeolla Province and the city of Jeongeup. The facility will combine radioisotope production, drug manufacturing and export. Construction is scheduled to begin in mid-2027, targeting a 2029 opening.
This is a preview of subscription content, access via your institution
Access options
Access through your institution
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Biotech news from around the world. Nat Biotechnol 44, 1594 (2026). https://doi.org/10.1038/s41587-026-03347-2
-
Published:
-
Version of record:
-
Issue date:
-
DOI: https://doi.org/10.1038/s41587-026-03347-2